Document is current
Any future updates will be listed below
-
Authors
Fourati, Slim https://orcid.org/0000-0001-6609-7587
Tomalin, Lewis E. https://orcid.org/0000-0003-4545-7138
Mulè, Matthew P.
Chawla, Daniel G. https://orcid.org/0000-0001-7667-9337
Gerritsen, Bram https://orcid.org/0000-0001-7065-3160
Rychkov, Dmitry
Henrich, Evan
Miller, Helen E. R.
Hagan, Thomas https://orcid.org/0000-0002-5254-5251
Diray-Arce, Joann
Dunn, Patrick https://orcid.org/0000-0003-1868-9689
,
Deckhut-Augustine, Alison
Haddad, Elias K.
Hafler, David A.
Harris, Eva
Farber, Donna
McElrath, Julie
Montgomery, Ruth R.
Peters, Bjoern
Rahman, Adeeb
Reed, Elaine F.
Rouphael, Nadine
Fernandez-Sesma, Ana
Sette, Alessandro
Stuart, Kenneth D.
Togias, Alkis
Levy, Ofer https://orcid.org/0000-0002-5859-1945
Gottardo, Raphael
Sarwal, Minnie M.
Tsang, John S. https://orcid.org/0000-0003-3186-3047
Suárez-Fariñas, Mayte
Pulendran, Bali https://orcid.org/0000-0001-6517-4333
Kleinstein, Steven H. https://orcid.org/0000-0003-4957-1544
Sékaly, Rafick-Pierre https://orcid.org/0000-0002-7816-4828
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI118608, U19AI090023, U19AI089992, U19AI128910, U19AI118610)
- License Information
-
More Information
Article History
Received: 20 April 2022
Accepted: 12 September 2022
First Online: 31 October 2022
Competing interests
: O.L. is a named inventor on patents held by Boston Children’s Hospital regarding human in vitro systems modeling vaccine action and vaccine adjuvants. B.P. serves on the External Immunology Network of GSK, and on the scientific advisory board of Medicago, CircBio, Sanofi, EdJen and Boehringer-Ingelheim. S.H.K. receives consulting fees from Northrop Grumman and Peraton. T.H. owns stock in GSK and Pfizer. The remaining authors declare no competing interests.
